By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Teva

Israel’s Teva agrees to pay $450m in settlements in US kickback, price-fixing cases The Times of Israel16:57Israeli Settlements Pharma Israel

Teva pharma to pay $450 million to settle kickback and price-fixing allegations Compliance Week20:54Israeli Settlements Pharma Israel

Teva pays $450M to resolve alleged kickback, price-fixing schemes Benzinga17:58Pharma

Teva agrees to pay $450m to resolve kickback allegations, US Justice Dept says Yahoo! US21:27Pharma

Teva, US agree to $450 million settlement in kickback case (1) Bloomberg Law23:20DOJ Pharma

Teva pays $450 million to settle kickback scheme charges UPI04:10Pharma DOJ

Teva and mAbxience partner to develop biosimilar candidate for oncology Pharmaceutical Technology12:00mAbxience Pharma

Teva, mAbxience enter licensing deal for development of anti Pd-1 oncology biosimilar candidate RTT News14:43mAbxience Pharma

Cancer patients abandoned when fentanyl painkillers discontinued Pain News Network15:31Pharma Cancer Treatment Cancer

Teva Pharmaceuticals settles overtime comp suit for $2.7 Million Bloomberg Law23:01Israeli Settlements Pharma Middle East

Teva touts safety profile of once monthly schizophrenia therapy Pharmaceutical Technology15:48Personality Disorder Pharma Schizophrenia

Teva touts safety profile of once-monthly schizophrenia therapy Clinical Trials Arena15:32Personality Disorder Pharma Schizophrenia

Teva pharma: FDA to review bla for tvb-009P - Quick facts RTT News12:43Pharma FDA

Teva settles opioid suits in Israel Globes08:31Opioid Crisis Israeli Settlements Israel

Latest News

In the last 8 hours

Israel’s Teva agrees to pay $450m in settlements in US kickback, price-fixing cases The Times of Israel16:57

Yesterday

Teva pharma to pay $450 million to settle kickback and price-fixing allegations Compliance Week20:54 11-Oct-24

Teva to pay $450M to settle allegations of kickbacks and generic drug price-fixing ENDPOINTS18:22 11-Oct-24

Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes Benzinga17:58 11-Oct-24

Teva hands over $450M to resolve kickback lawsuits involving MS drug Copaxone and generics FiercePharma14:39 11-Oct-24

Generic Pharmaceutical Company Pays $25 Million to Resolve False Claims Act Liability for Price-Fixing of Generic Drugs U.S. Department of Justice (Press Release)10:11 11-Oct-24

Teva to pay $450 million over Copaxone price inflation CTech09:55 11-Oct-24

Teva pays $450 million to settle kickback scheme charges UPI04:10 11-Oct-24

Israeli-American drugmaker settles kickback, price-fixing claims for $450 million Courthouse News01:50 11-Oct-24

In the last 7 days

Teva, US Agree to $450 Million Settlement in Kickback Case (1) Bloomberg Law23:20 10-Oct-24

BREAKING: Teva To Pay $450M To Settle Kickback Cases Law36022:00 10-Oct-24

Teva agrees to pay $450m to resolve kickback allegations, US Justice Dept says Yahoo! US21:27 10-Oct-24

Drug Maker Teva Pharmaceuticals Agrees to Pay $450M in False Claims Act Settlement to Resolve Kickback Allegations… U.S. Department of Justice (Press Release)21:11 10-Oct-24

Peptide Therapeutics Market and Industry Forecast 2024-2032: Total Revenues Forecast to Reach $86.9 Billion by 2032,… GlobeNewswire (Press Release)11:36 10-Oct-24

Teva Pharma: FDA To Review Bla For Tvb-009P - Quick Facts RTT News12:43 8-Oct-24

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA GlobeNewswire (Press Release)12:08 8-Oct-24

In the last month

Cancer Patients Abandoned When Fentanyl Painkillers Discontinued Pain News Network15:31 4-Oct-24

Teva and mAbxience partner to develop biosimilar candidate for oncology Pharmaceutical Technology12:00 4-Oct-24

Global Huntington's Disease Treatment Market Research 2024-2032 Featuring H Lundbeck, Pfizer,… Business Wire (Press Release)16:00 3-Oct-24

Teva, MAbxience Enter Licensing Deal For Development Of Anti Pd-1 Oncology Biosimilar Candidate RTT News14:43 3-Oct-24

Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate GlobeNewswire (Press Release)13:31 3-Oct-24

Teva Sales Workers Get $2.7M Unpaid OT Deal Approved Law36017:47 2-Oct-24

Teva Trailwinder Low review: Finally, a comfortable pair of walking shoes I can wear every day Woman and Home12:34 2-Oct-24

Teva Pharmaceuticals Settles Overtime Comp Suit for $2.7 Million Bloomberg Law23:01 1-Oct-24

Teva Pharma Launches Octreotide Acetate For Injectable Suspension - Quick Facts RTT News14:12 1-Oct-24

Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for… GlobeNewswire (Press Release)13:40 1-Oct-24

$1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today Benzinga01:43 1-Oct-24

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024 GlobeNewswire (Press Release)21:31 30-Sept-24

The Mandalorian & Grogu: All Confirmed Cast & Characters (So Far) ScreenRant19:05 30-Sept-24

Epinephrine Autoinjectors Industry Research Business Report 2024 Featuring ALK-Abello, Bausch + Lomb, Emerade, Teva… GlobeNewswire (Press Release)16:44 26-Sept-24

IEFA, SE, TEVA, AER: ETF Inflow Alert Nasdaq16:36 26-Sept-24

Take advantage of the fall hiking season in Teva’s cool and comfortable Trailwinders Rock Hill Herald10:51 26-Sept-24

Teva settles opioid suits in Israel Globes08:31 26-Sept-24

Autoinjectors Market Global Forecast Report to 2035, Featuring Profiles of Antares Pharma, Elcam Medical, Oval Medical… GlobeNewswire (Press Release)16:28 25-Sept-24

Teva touts safety profile of once monthly schizophrenia therapy Pharmaceutical Technology15:48 23-Sept-24

Teva touts safety profile of once-monthly schizophrenia therapy Clinical Trials Arena15:32 23-Sept-24

Medincell’s Partner Teva Presented New Efficacy, Safety, and Tolerability Data from Pivotal… Business Wire (Press Release)07:07 23-Sept-24

Medincell’s Partner Teva Provided Treatment Insights into Switching to UZEDY® from Perseris® Business Wire (Press Release)07:04 23-Sept-24

Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement… GlobeNewswire (Press Release)06:06 23-Sept-24

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as … GlobeNewswire (Press Release)09:21 21-Sept-24

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY®… GlobeNewswire (Press Release)09:11 21-Sept-24

Women's Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030) Featuring Profiles of… GlobeNewswire (Press Release)09:22 18-Sept-24

Paul Sun-Hyung Lee Confirms His Mandalorian Character's Surprising Princess Leia Connection ScreenRant20:03 17-Sept-24

NZNO Urges Pharmac To Take Israeli Drug Company Off Its List Scoop12:00 15-Sept-24

TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold? Zacks19:35 13-Sept-24

Global Buccal Drug Delivery Systems Market Research 2024-2030 Featuring Johnson & Johnson, Pfizer, Sanofi, Novartis,… GlobeNewswire (Press Release)11:59 12-Sept-24

view more headlines

12 Oct 16:57

Teva News

NewsNow brings you the latest news from the world’s most trusted sources on Teva. NewsNow aims to be the world’s most accurate and comprehensive Teva news aggregator, bringing you the latest headlines automatically and continuously 24/7.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.